Company / Operating Income per Share
Aclaris Therapeutics, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.71
FY2025
5-year range
-$1.99 / -$0.71
FY2021-FY2025
Trend
+48.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 9 years, ranging from $-2.75 in FY2018 to $-0.71 in FY2025.
Based on SEC 10-K filings.
-0.71 in FY2025.
Improved from $-1.35 to $-0.71 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 48.4% year-over-year.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.71 | +48.4% |
| FY2024 | -$1.37 | -2.1% |
| FY2023 | -$1.35 | +8.3% |
| FY2022 | -$1.47 | +26.2% |
| FY2021 | -$1.99 | +2.7% |
| FY2020 | -$2.04 | -54.9% |
| FY2019 | -$1.32 | +52.0% |
| FY2018 | -$2.75 | -246.4% |
| FY2017 | -$0.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026